In addition, our data revealed the effects of RBP4 of DEGs that are important to pathways in GCs, including oxidative phosphorylation, NAFLD, Alzheimer’s disease, fatty acid biosynthesis, AMPK signaling pathway, and insulin signaling pathway. This evidence concerns the gene RBP4 and metabolic dysfunction-associated steatotic liver disease.